Core--Cryopreservation and Embryo Derivation
核心--冷冻保存与胚胎衍生
基本信息
- 批准号:7205469
- 负责人:
- 金额:$ 29.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:biomedical facilitycryopreservationembryo /fetus preservationembryonic stem cellgene mutationgene targetinggenetic straingenetic susceptibilitygenetically modified animalshost organism interactionimmunogeneticsin vitro fertilizationlaboratory mousemicroinjectionsmicroorganism immunologyvirus diseases
项目摘要
The functions of the Cryopreservation and Embryo Derivation Core are: A) to expeditiously transfer mutant
mice created by the Osaka group in Japan to the La Jolla group. B) to rederive frozen embryos shipped from La
Jolla to Osaka. C) to generate ES cell-derived chimeric mice for the establishment of knockout mice by
microinjection of ES cells into mouse blastocysts and implantation. D) to submit mutant mouse strains to the
MMRRC for distribution to the scientific community. Generation of mouse models have made major
contributions to recent advances in the field of innate immunity. In the proposed project to investigate anti-viral
immune responses by both forward and reverse genetics, close collaboration between the La Jolla group
(conducting mouse forward genetics) and the Osaka group (conducting mouse reverse genetics) will be
essential for success. We will exchange mutant mice and will study them in parallel using different viruses. We
will also analyze signaling pathways based on the outcome of experiments in which ENU-induced mutations
and knockout mutations are combined. A rapid and safe means of exchange, circumventing quarantine and
allowing quick assessments, will be provided by this Core. The Core will also be responsible for the
microinjection of ES cells into mouse blastocysts and re-derivation from the embryos for generating knockout
mice. Finally, the Core will also send mutant mouse strains generated in Osaka to the MMRRC for distribution
to the scientific community, permitting accelerated research in many laboratories worldwide.
冷冻保存和胚胎衍生核心的功能是:A)快速转移突变体
将日本大坂小组制造的小鼠转移到拉霍亚小组。B)将从洛杉矶运来的冷冻胚胎重新衍生
Jolla到大坂。C)通过以下步骤产生ES细胞衍生的嵌合小鼠用于建立敲除小鼠:
将ES细胞显微注射到小鼠胚泡中并植入。D)将突变小鼠品系提交给
MMRRC分发给科学界。小鼠模型的产生已经使主要的
对先天免疫领域最新进展的贡献。在研究抗病毒药物的拟议项目中,
免疫反应的正向和反向遗传学,密切合作之间的拉霍亚小组
(进行小鼠正向遗传学)和大坂组(进行小鼠反向遗传学)将在
成功的关键。我们将交换突变小鼠,并使用不同的病毒进行平行研究。我们
还将根据ENU诱导突变的实验结果分析信号通路,
和敲除突变的组合。一种快速安全的交换方式,绕过检疫,
允许快速评估,将由该核心提供。核心还将负责
将ES细胞显微注射到小鼠囊胚中并从胚胎中再衍生以产生敲除
小鼠最后,核心还将把在大坂产生的突变小鼠品系送到MMRRC进行分发
科学界,允许在世界各地的许多实验室加速研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shizuo Akira其他文献
Shizuo Akira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shizuo Akira', 18)}}的其他基金
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
8513876 - 财政年份:2006
- 资助金额:
$ 29.52万 - 项目类别:
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
8871658 - 财政年份:2006
- 资助金额:
$ 29.52万 - 项目类别:
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
8365280 - 财政年份:2006
- 资助金额:
$ 29.52万 - 项目类别:
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
7202834 - 财政年份:2006
- 资助金额:
$ 29.52万 - 项目类别:
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
7481090 - 财政年份:
- 资助金额:
$ 29.52万 - 项目类别:
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
抗病毒耐药机制的反向遗传分析
- 批准号:
7905006 - 财政年份:
- 资助金额:
$ 29.52万 - 项目类别:
相似国自然基金
荷人卵巢上皮癌裸鼠冻融卵巢组织移植的安全性研究
- 批准号:30960408
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
A National NHP Embryo Resource of Human Genetic Disease Models
国家NHP人类遗传病模型胚胎资源
- 批准号:
10556087 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery
小儿心脏手术中植入生物材料加速钙化和结构退化的机制
- 批准号:
10655959 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
United for Health Equity - Living PDX Program (U4HELPP)
United for Health Equity - Living PDX 计划 (U4HELPP)
- 批准号:
10733310 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Identification of Genetic Variants that Influence Compulsive Alcohol Intake in Outbred Rats
影响近交系大鼠强迫性饮酒的遗传变异的鉴定
- 批准号:
10585109 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Conditional male lethal Anopheles stephensi line for the efficient manufacture of malaria vaccines
用于高效生产疟疾疫苗的条件性雄性致死史氏按蚊品系
- 批准号:
10602811 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Omics interrogation of functionally competent hematopoieitic stem cells
功能健全的造血干细胞的组学研究
- 批准号:
10571101 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Cell Therapy Program with Scale-up cGMP Manufacturing of Human Corneal Stromal Stem Cells
细胞治疗计划,扩大人类角膜基质干细胞的 cGMP 生产
- 批准号:
10720562 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Modulation of NOD Strain Diabetes by ENU-Induced Mutations
ENU 诱导突变对 NOD 菌株糖尿病的调节
- 批准号:
10642549 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:














{{item.name}}会员




